Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL249544 | 0.92 | — | — | |
| Hydrochloric Acid SCHEMBL28017818 | 0.89 | — | — | |
| Oxalic Acid SCHEMBL10896077 | 0.82 | TDP1 (0.39) | TDP1ALDH1A1RXFP1TGFBR1KDM4E | |
| SCHEMBL1905147 | 0.71 | TDP1 (0.80) | TDP1ALDH1A1TSHRLMNA | |
| Cyclohexane SCHEMBL347610 | 0.71 | TDP1 (0.80) | TDP1ALDH1A1TSHRLMNA | |
| Cyclohexane SCHEMBL2887999 | 0.71 | TDP1 (0.80) | TDP1ALDH1A1TSHRLMNA | |
| Cyclopropane SCHEMBL10359668 | 0.70 | ALDH1A1 (0.35) | TDP1ALDH1A1RXFP1TGFBR1KDM4E | |
| Cyclohexane SCHEMBL10642803 | 0.69 | TDP1 (0.75) | TDP1ALDH1A1LMNA | |
| SCHEMBL25316068 | 0.67 | ALDH1A1 (0.50) | TDP1ALDH1A1RXFP1TGFBR1KDM4E | |
| Methacrylic Acid SCHEMBL4134914 | 0.67 | TDP1 (0.44) | TDP1ALDH1A1TGFBR1KDM4ETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210403625-A1 | BORONIC ACID POLYMERS AND METHODS OF USE | GLYSCEND, INC. | 2021-12-30 | — | — | US | disclosed |
| EP-3852768-A1 | BORONIC ACID POLYMERS AND METHODS OF USE | Glyscend, Inc. (US) | 2021-07-28 | — | — | EP | disclosed |
| WO-2020061430-A1 | BORONIC ACID POLYMERS AND METHODS OF USE | GLYSCEND, INC. (US) | 2020-03-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210403625-A1 | BORONIC ACID POLYMERS AND METHODS OF USE | SLC10A2, SI, PYGL | TDP1 899/4885ALDH1A1 3561/4885RXFP1 1879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.